These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 27293205)
1. Will stem cells bring hope to pathological skin scar treatment? Li Q; Zhang C; Fu X Cytotherapy; 2016 Aug; 18(8):943-956. PubMed ID: 27293205 [TBL] [Abstract][Full Text] [Related]
2. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders. Ogawa R; Akaishi S Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277 [TBL] [Abstract][Full Text] [Related]
3. Theoretical and practical aspects of using fetal fibroblasts for skin regeneration. Li M; Zhao Y; Hao H; Han W; Fu X Ageing Res Rev; 2017 Jul; 36():32-41. PubMed ID: 28238941 [TBL] [Abstract][Full Text] [Related]
4. Overview about the keloid scars and the elaboration of a non-invasive, unconventional treatment. Carantino I; Florescu IP; Carantino A J Med Life; 2010; 3(2):122-7. PubMed ID: 20968196 [TBL] [Abstract][Full Text] [Related]
11. A new therapeutic protocol for the treatment of keloid scars: a retrospective study. Boccara D; Serror K; Chatelain S; Chaouat M; Mimoun M; Azoulay L J Wound Care; 2021 Mar; 30(3):184-190. PubMed ID: 33729847 [TBL] [Abstract][Full Text] [Related]
12. Pulsed dye laser versus long-pulsed Nd:YAG laser in the treatment of hypertrophic scars and keloid: A comparative randomized split-scar trial. Al-Mohamady Ael-S; Ibrahim SM; Muhammad MM J Cosmet Laser Ther; 2016 Aug; 18(4):208-12. PubMed ID: 26735516 [TBL] [Abstract][Full Text] [Related]
13. [Keloid scars of the head and neck]. Beogo R; Guiébré YM; Sérémé M; Ouoba K; Zwetyenga N Rev Stomatol Chir Maxillofac; 2012 Jun; 113(3):179-83. PubMed ID: 22515916 [TBL] [Abstract][Full Text] [Related]
14. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling. Fang F; Huang RL; Zheng Y; Liu M; Huo R J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019 [TBL] [Abstract][Full Text] [Related]
15. [Treatment methods of keloid and hypertrophic scar formation]. Wester JU; Pilegaard J; Hahn T Ugeskr Laeger; 1989 Jan; 151(4):223-5. PubMed ID: 2916252 [TBL] [Abstract][Full Text] [Related]
16. Hypertrophic scars and keloids: a recurrent problem revisited. Ellitsgaard V; Ellitsgaard N Acta Chir Plast; 1997; 39(3):69-77. PubMed ID: 9439007 [TBL] [Abstract][Full Text] [Related]
17. [Prevention and treatment of pathological scars]. Petit Jornet JM; Teixidó Vidal X; Magrans Abril A; Cuixart Llopis S Rev Enferm; 2004 Jan; 27(1):7-12. PubMed ID: 15040590 [TBL] [Abstract][Full Text] [Related]
18. Keloids: current concepts of pathogenesis (review). Bran GM; Goessler UR; Hormann K; Riedel F; Sadick H Int J Mol Med; 2009 Sep; 24(3):283-93. PubMed ID: 19639219 [TBL] [Abstract][Full Text] [Related]
19. Regenerative healing, scar-free healing and scar formation across the species: current concepts and future perspectives. Ud-Din S; Volk SW; Bayat A Exp Dermatol; 2014 Sep; 23(9):615-9. PubMed ID: 24863070 [TBL] [Abstract][Full Text] [Related]
20. [Advances in the research of signaling pathway in pathologic scar formation]. Jin J; Ma B; Xia ZF Zhonghua Shao Shang Za Zhi; 2017 Mar; 33(3):152-155. PubMed ID: 28316164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]